インデックス付き
- Jゲートを開く
- Genamics JournalSeek
- アカデミックキー
- ジャーナル目次
- グローバル インパクト ファクター (GIF)
- 中国国家知識基盤 (CNKI)
- ウルリッヒの定期刊行物ディレクトリ
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- OCLC-WorldCat
- パブロン
- ジュネーブ医学教育研究財団
- ユーロパブ
- Google スカラー
このページをシェアする
ジャーナルチラシ
概要
Recents Trends for the Treatment of Colon Cancer
Nidhi Sachan*, Pramod Kumar Sharma, Mohammad Aftab Alam, Rishabh Malviya
Cancer is a deadly disease which is spreading across the world at a relatively high rate is a group of diseases involving cell growth which have a capability to invade and move to the other parts of the human body cancer can develop in any organ of the human body like colon, lungs basal cell, prostate, breast. The colon cancer begins as a non-cancerous polyp. These often have no sumptuous but later on they are detected by screening. The symptoms depend on the basis of size and location of the cancer. The treatment also depends on the same. Frequently used anti-cancer used drugs 5-Fluoro uracil, methotrexate, capecitabine, etc. which inhibit the abnormal cell growth by preventing the replication of DNA in the tumors cells. In this review report we focus on recents trends for the treatment of colon cancer. 5-fluoro uracil is most commonly used drug for the treatment of colon cancer and act by inhibiting thymidylate synthatase enzyme.